- Home
- CNEY vs BFRI Comparison
CNEY vs BFRI Comparison
Compare CNEY & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNEY
- BFRI
- Stock Information
- Founded
- CNEY 2018
- BFRI 1997
- Country
- CNEY China
- BFRI United States
- Employees
- CNEY N/A
- BFRI N/A
- Industry
- CNEY Major Chemicals
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- CNEY Industrials
- BFRI Health Care
- Exchange
- CNEY Nasdaq
- BFRI Nasdaq
- Market Cap
- CNEY 11.3M
- BFRI 10.6M
- IPO Year
- CNEY 2021
- BFRI 2021
- Fundamental
- Price
- CNEY $1.80
- BFRI $1.07
- Analyst Decision
- CNEY
- BFRI Strong Buy
- Analyst Count
- CNEY 0
- BFRI 1
- Target Price
- CNEY N/A
- BFRI $2.75
- AVG Volume (30 Days)
- CNEY 14.3K
- BFRI 97.6K
- Earning Date
- CNEY 01-01-0001
- BFRI 11-13-2025
- Dividend Yield
- CNEY N/A
- BFRI N/A
- EPS Growth
- CNEY N/A
- BFRI N/A
- EPS
- CNEY N/A
- BFRI N/A
- Revenue
- CNEY $36,049,275.00
- BFRI $39,188,000.00
- Revenue This Year
- CNEY N/A
- BFRI $9.70
- Revenue Next Year
- CNEY N/A
- BFRI $12.58
- P/E Ratio
- CNEY N/A
- BFRI N/A
- Revenue Growth
- CNEY N/A
- BFRI 11.20
- 52 Week Low
- CNEY $1.56
- BFRI $0.54
- 52 Week High
- CNEY $21.61
- BFRI $1.87
- Technical
- Relative Strength Index (RSI)
- CNEY 35.89
- BFRI 56.19
- Support Level
- CNEY $1.80
- BFRI $1.00
- Resistance Level
- CNEY $1.96
- BFRI $1.15
- Average True Range (ATR)
- CNEY 0.11
- BFRI 0.07
- MACD
- CNEY -0.01
- BFRI 0.00
- Stochastic Oscillator
- CNEY 14.71
- BFRI 60.00
About CNEY CN Energy Group Inc.
CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.